Company research
AngioGenex, Inc.
CIK 1085596Updated Nov 16, 2026
Securities
Historical securities (1)
AGGX · OTC · equity · closed Mar 13, 2023Name history
ECLIC INC/NV · through Jan 5, 2006
AGGX price & chart
Historical security
This listing closed Mar 13, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2018 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 52,819Source | 515,310Source | 272,471Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 493,676Source | 272,471Source |
| Assets, CurrentUSD | 52,819Source | 515,310Source | 272,471Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 1,123,564Source | — | — |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 29,387Source | 29,387Source | 25,367Source |
| Additional Paid in CapitalUSD | 5,911,585Source | 5,892,359Source | 5,116,065Source |
| Retained Earnings (Accumulated Deficit)USD | -7,011,717Source | -6,576,269Source | -5,893,240Source |
| Stockholders' Equity Attributable to ParentUSD | -1,070,745Source | -654,523Source | -750,808Source |
| Liabilities and EquityUSD | 52,819Source | 515,310Source | 272,471Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 1,096,114Source | 1,142,383Source | 995,829Source |
cash flow · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -453,789Source | -528,795Source | -83,415Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -20,304Source | 750,000Source | 355,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 11,999Source | 4,345Source | 0Source |
| Additional Financial Items | |||
| General and Administrative ExpenseUSD | 406,923Source | 354,852Source | 388,525Source |
| Net Income (Loss) Attributable to ParentUSD | -435,448Source | -683,029Source | -448,527Source |
| Operating ExpensesUSD | 437,659Source | 646,188Source | 437,958Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 750,000Source | 350,000Source |
income statement · annual statements
| Line item | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Operating Income (Loss)USD | -437,659Source | -646,188Source | -437,958Source |
| Net Income (Loss) Attributable to ParentUSD | -435,448Source | -683,029Source | -448,527Source |
| Additional Financial Items | |||
| Current Income Tax Expense (Benefit)USD | 11,146Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | 406,923Source | 354,852Source | 388,525Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -446,594Source | -683,029Source | -448,527Source |
| Interest ExpenseUSD | -9,958Source | -36,073Source | -10,722Source |
| Interest Income (Expense), NetUSD | -711Source | — | — |
| Operating ExpensesUSD | 437,659Source | 646,188Source | 437,958Source |
| Other ExpensesUSD | 8,935Source | -36,841Source | -10,569Source |
| Research and Development ExpenseUSD | 30,736Source | 291,336Source | 49,433Source |